NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St indexes climb after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
NovaBay Pharma (NBY) Misses Q4 EPS by 15c
August 13, 2024 4:22 PM EDTNovaBay Pharma (NYSE: NBY) reported Q4 EPS of ($1.37), $0.15 worse than the analyst estimate of ($1.22). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $3.15 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
... More